Skin cancers in organ transplant recipients

Long‐term utilization of immunosuppression in organ transplant recipients (OTRs) leads to decreased immune‐mediated tumour surveillance and development of malignant tumours a delicate balance needs to be maintained in the intensity of immunosuppression to keep the risk of malignancy low without jeopardizing life‐saving graft function. OTRs are prone to developing skin cancers that exhibit unique epidemiologic, pathophysiologic, and prognostic characteristics

  • Squamous Cell Carcinoma
  • Skin cancer screening
  • Pathogenesis
  • Actinic Keratoses
  • Systemic chemoprophylaxis
  • Staging of cutaneous SCCs
  • Metastatic Cutaneous SCC
  • Kaposi Sarcoma
  • Merkel Cell Carcinoma
  • Rare Cutaneous Tumours

Related Conference of Skin cancers in organ transplant recipients

November 17-18, 2025

8th International Dermatology Conference: Skin and Body

Paris, France
December 08-09, 2025

28th Global Summit on Dermatology, Skin Development and Ageing

Toronto, Canada
December 08-09, 2025

30th International Conference on Dermatology & Skin Care

Paris, France
January 22-23, 2026

15th International Conference on Cosmetology, Beauty and Dermatology

Bangkok, Thailand
February 05-06, 2026

9th Annual Conference on Skin Cancer and Dermatology

Paris, France
March 23-24, 2026

4th World Congress on Skin care, Dermatology and Allergic Diseases

Paris, France
May 07-08, 2026

9th World Cosmetic and Dermatology Congress

Paris, France
June 04-05, 2026

8th Geriatrics and Healthcare Conference: For a better Aging Care

Zurich, Switzerland
June 22-23, 2026

28th World Dermatology and Aesthetic Congress

London, UK
August 25-26, 2026

26th European Dermatology Congress

Paris, France

Skin cancers in organ transplant recipients Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in